Navigation Links
Biogen Idec's baminercept alfa shows promise in patients with rheumatoid arthritis
Date:6/12/2008

b trials to study baminercept alfa in combination with methotrexate in patients with moderate to severe RA. 1.) the REACT study for patients with an inadequate response to treatment with DMARD therapy (disease-modifying antirheumatic drug), which completed enrollment earlier this year, and 2.) the RESPOND study for patients having an inadequate response to a TNF inhibitor (biologic therapies that target the TNF pathway). A decision to enter into Phase III development will be made sometime towards the end of 2008 pending analysis of the results of Phase IIb studies.

Rheumatoid Arthritis and the LT- Pathway

In patients with RA, certain immune cells malfunction and attack the joints, causing painful and chronic inflammation as well as destruction of cartilage, tendons and bones. As in other autoimmune diseases, the immune system mistakes healthy cells for foreign invaders. Though the exact cause of RA is unknown, new research is uncovering the immunologic and genetic factors that play important roles in triggering and perpetuating inflammation of the joints.

As shown in preclinical studies, baminercept alfa is thought to inhibit the function of LT- and LIGHT, two critical components of the LT- pathway implicated in the progression of RA and other autoimmune diseases. These molecules are novel members of the TNF superfamily, distinct from TNF- and lymphotoxin- targeted by some biologics indicated for RA. Autoimmune diseases are in part characterized by the inappropriate emergence of organized immune cell collections, or lymphoid structures, at sites of inflammation or in immune system tissues. Baminercept alfa is thought to act by inhibiting the formation and maintenance of lymphoid structures and the consequent activation of aberrant immune effector cells implicated in the pathogenesis of autoimmune diseases such as RA. By blocking inappropriate signals from cell-surface LT- and LIGHT
'/>"/>

Contact: Rachi Govil
rachi.govil@offspringpr.com
212-798-9827
Offspring PR
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Broad Stakeholder Coalition Concludes that the Pathway for Biosimilars Act Fails to Ensure Timely Access to Safe, Affordable Biogeneric Medicines for Patients
2. New MedPAC Report: Abbreviated Biogenerics Pathway Urgently Needed
3. PCMA 2008 Agenda: Support E-Prescribing, Biogenerics; Oppose Bills that Increase Costs
4. Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States
5. New Bird Flu Vaccine Shows Promise
6. New research shows room for improvement in health news
7. Opting out revolution a myth: Study shows steep employment gains for women, mothers
8. New KLRI Reports Shows Longevity Science Moving Beyond Studying the Obvious to the Downward Spiral Paradigm in the Aging Process
9. New Treatment Shows Promise for Excessive Drinking
10. New Heart Ultrasound Research Shows Hope for Diagnosing and Treating Fatal Heart Conditions
11. Blood Cancer Drug Shows Promise Against Lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... researchers have been awarded two-year grants for their work ... month. Of the 110 initial submissions to the new ... only four projects were funded, three of which are ... M.D., Ph.D.; G. William Wong, Ph.D.; and Elias Zambidis, ... oncology, will use his $500,000 proof of principle grant ...
(Date:4/18/2014)... WA April 18, 2014) Benaroya Research Institute ... research how blocking a particular molecule in metastatic breast ... the number of lung metastases. BRI scientists have found ... can shrink tumors by 60 - 80 percent and ... the lung. The $1.8 million five-year grant comes from ...
(Date:4/18/2014)... 18, 2014) ― A new study in the ... in health-related Google searches reveals a recurring pattern that ... , Investigators from San Diego State University, the ... Campaigns, analyzed "healthy" Google searches (searches that included the ... originating in the U.S. from 2005 to 2012. They ...
(Date:4/18/2014)... Northwestern Medicine scientists could lead to potential new treatments ... with scleroderma. , Fibrosis, or scarring, is a ... skin and lungs can lead to serious organ damage ... new therapeutic options centers on findings made by Swati ... the role that a specific protein plays in promoting ...
(Date:4/17/2014)... show signs of chronic inflammation in non-cancerous prostate tissue ... prostate cancer than those with no inflammation, according to ... the Johns Hopkins Kimmel Cancer Center. , The link ... men with so-called high-grade prostate cancer those with ... the presence of the most aggressive and rapidly growing ...
Breaking Medicine News(10 mins):Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New research shows people are thinking about their health early in the week 2Health News:New clues on tissue scarring in scleroderma 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3
... premature and more than one in ten infants in ... of the common problems associated with premature births is brittle ... fractures and rickets in the infant, and osteoporosis later in ... a training program that aims to make preemies bones stronger. ...
... State University professor will share a $3.3 million federal ... to develop an innovative method that will help smokers ... Professor Brad Schmidt and UVM psychology Professor Michael Zvolensky ... campus -- to participate in the study over the ...
... growing body of research in the field of cancer ... the launch of a major peer-reviewed scientific journal, Cancer ... new journal is the first in the world dedicated ... trials. , In the past, scientists and interested readers ...
... The long-held idea that only vertebrates have sophisticated adaptive ... many pathogens after being infected by them just once ... that many insects also have a form of immune ... they have previously encountered. This was just one of ...
... Gift of Mobility To Make Life Easier for Double ... WHO: Army Specialist Thomas Graham, 24, recent Iraqi ... at The SCOOTER Store, Baltimore,location, WHAT: The delivery ... Despite, the recent loss of both legs while deployed ...
... Dynatronics to Repurchase Up to $250,000 of the Company,s ... Dynatronics,Corporation (Nasdaq: DYNT ) today announced that ... repurchase program of the company,s common,stock by $250,000., ... board of,directors in the future of the company and ...
Cached Medicine News:Health News:Tel Aviv University gives preemies a fighting chance 2Health News:FSU researcher lands $3.3 million grant to help smokers kick habit 2Health News:AACR introduces Cancer Prevention Research 2Health News:AACR introduces Cancer Prevention Research 3Health News:Violent sex acts boost insect's immunity system 2Health News:Violent sex acts boost insect's immunity system 3Health News:Dynatronics Announces $250,000 Increase in Stock Buyback Program 2
(Date:1/15/2014)... Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... from institutional investors to purchase an aggregate of approximately ... at-the-market registered direct offering, led by a dedicated health ... purchase agreements with these investors pursuant to which the ...
(Date:1/15/2014)... FORT WORTH, Texas , Jan. 15, 2014  Humberto ... in Dermatology Achievement Award" from the Journal of ... Dermatology Aesthetic & Clinical Conference (ODAC). The event is January ... Florida . The ...
(Date:1/15/2014)... , Jan. 15, 2014  In an unprecedented effort to curb ... in ambulances and other transport vehicles, an advanced and portable UV ... personnel for the first time. In order to ... these deadly pathogens, West Palm Beach Fire ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2
... to the American Diabetes Association, total costs of diagnosed ... at $174 billion.  Millions of Americans have been diagnosed ... that they are at risk or in fact living ... pills to manage their diabetes and these medications can ...
... Mass., Nov. 1, 2010 Hologic, Inc. (Hologic ... a leading developer, manufacturer and supplier of premium ... dedicated to serving the healthcare needs of women, ... American Society of Breast Surgeons (ASBS) MammoSite® Breast ...
Cached Medicine Technology:Stater Bros. Super Rx Pharmacy Offers FREE Diabetic Medications 2Hologic Announces Long-term, Five-year Results from MammoSite® ASBS Registry Study 2Hologic Announces Long-term, Five-year Results from MammoSite® ASBS Registry Study 3
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: